WO2005067884A1 - しわ改善用皮膚外用剤 - Google Patents
しわ改善用皮膚外用剤 Download PDFInfo
- Publication number
- WO2005067884A1 WO2005067884A1 PCT/JP2005/000332 JP2005000332W WO2005067884A1 WO 2005067884 A1 WO2005067884 A1 WO 2005067884A1 JP 2005000332 W JP2005000332 W JP 2005000332W WO 2005067884 A1 WO2005067884 A1 WO 2005067884A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- film
- external preparation
- polyurethane
- skin
- diol
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/895—Polysiloxanes containing silicon bound to unsaturated aliphatic groups, e.g. vinyl dimethicone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/87—Polyurethanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L75/00—Compositions of polyureas or polyurethanes; Compositions of derivatives of such polymers
- C08L75/04—Polyurethanes
Definitions
- the present invention relates to a skin external preparation for improving wrinkles. More specifically, the present invention relates to a skin external preparation for improving wrinkles, which improves wrinkles by a film formed in a drying process when the external preparation for skin is applied to the skin.
- a film agent has been used as a skin external preparation for the purpose of improving skin wrinkles.
- the use of a film agent utilizes the property of the film shrinking during the drying process during film formation, and the film shrinkage force pulls up fine lines on the skin, improving the feeling of stickiness and temporarily It was based on the idea of removing fine lines. For this reason, a skin agent having a strong contraction force and forming a hard film has been used.
- a film agent mixed with a wrinkle improver using a polymer having a strong shrinkage force for example, a polyurethane (see Patent Document 1) is known, and an acrylic resin, a butyl acetate-based resin and the like are also known. Film forming properties of resin, polyethylene resin, silicon resin, polybutyl resin, polybutyl alcohol, acrylic water-soluble resin, cellulose water-soluble resin, starch and derivatives thereof, gelatin, sodium alginate, etc. Research has been conducted to improve the wrinkles by forming a film having a high contraction force by a polymer (for example, see Patent Document 2).
- Patent Document 1 Japanese Unexamined Patent Publication No. 11-504949
- Patent Document 2 Japanese Patent Application Laid-Open No. 5-933
- the present invention has been made in view of the above circumstances, and an object of the present invention is to provide a skin external preparation for wrinkle improvement which is excellent in wrinkle improvement effect, usability, and usability.
- the inventors of the present invention have conducted intensive studies to solve the above-mentioned problems. As a result, a specific polymer, specifically, an aqueous dispersion of polyurethane and an acrylic polymer, which forms a film having a low shrinkage force, was formulated. It has been found that the above problems can be solved by preparing a skin external preparation, and the present invention has been completed.
- the present invention is based on the idea of "filling wrinkles with a film” with a film that does not shrink, rather than based on the conventional idea of using a contracting film, and has led to the present invention. . That is, by using the polyurethane and the acrylic polymer, the film formed on the skin by the application of the skin external preparation for improving wrinkles of the present invention does not shrink and harden as in the past, and the According to a different mechanism of action, a skin external preparation for improving wrinkles having a better function than before has been obtained.
- the present invention relates to an external preparation for skin containing a polymer aqueous dispersion in which a water-insoluble film-forming polymer is dispersed in water, wherein the main component of the film-forming polymer is A skin external preparation for improving wrinkles, characterized by being a polyurethane having a shrinkage of 20% or less and an acrylic polymer having a film formation shrinkage of 20% or less.
- the film-forming polymer is a polymer that forms a film on the skin and the substrate when the aqueous dispersion of the polymer is applied to the skin and the substrate and dried.
- the polyurethane is preferably a polyurethane obtained by reacting an isocyanate compound with a diol compound containing a polyether diol, a polycarbonate diol, and a carboxyl group-containing alkylene diol. Preferably contains isophorone diisocyanate.
- the polyether diol is polytetramethylene glycol
- the polycarbonate diol is polyhexamethylene carbonate diall
- the carboxyl group-containing alkylene diol is dimethylolpropionic acid and Z or dimethylolbutanoic acid.
- the acrylic polymer is preferably a polymer of a monomer containing ethyl acrylate as a main component.
- the aqueous acrylic polymer dispersion contains a sulfonated polybutyl alcohol.
- the polyurethane has a film strength of 300 to 700 kgZcm 2 and the acrylic polymer has a film strength of 0.1 to 100 kg / cm 2 .
- the film elongation of polyurethane is 200-500%, and the film elongation of acrylic polymer is 5%.
- the average particle size of the polyurethane in the aqueous polyurethane dispersion is 10 to 300 nm, and the average particle size of the acrylic polymer in the aqueous acrylic polymer dispersion is 100 to 600 nm.
- the polyurethane dispersion in the aqueous polyurethane dispersion is composed of a mixture having an average particle size of 20 to 60 ⁇ m and an average particle size of 150 to 200 nm.
- the skin external preparation for improving wrinkles of the present invention preferably contains polyurethane in an amount of 110 to 10% by mass based on the total amount of the external preparation for skin and an acrylic polymer in an amount of 110 to 20% by mass based on the total amount of the external preparation for skin.
- flaky silica may be further contained.
- the inclusion of flaky silica increases the thickness of the film formed from the aqueous dispersion in which the polymer is dispersed, enhances and enhances the effect of improving wrinkles, and responds to skin elasticity and skin movement over a long period of time.
- a skin external preparation for improving wrinkles which can be obtained can be obtained.
- the shrinking force in the present invention is a force for shrinking when an aqueous dispersion in which a polymer is dispersed forms a film, and the force is evaluated by a film forming shrinkage rate.
- the film shrinkage rate is the degree of shrinkage of a thin layer of an aqueous dispersion in which a polymer is dispersed, when the thin film is dried to form a film.
- an aqueous dispersion in which a polymer in an amount of 1 g in terms of solid content is dispersed is poured into a 5 cm X 5 cm polyethylene mold so as to have a thickness of about 0.5 mm, and a predetermined temperature (50 ° C )), The length and width of the film obtained by drying for a predetermined time (room temperature 3 days) are measured and calculated according to the following formula.
- Film formation shrinkage (%) [(longitudinal measurement value x horizontal measurement value) / 25] X 100
- the film strength and film elongation of a polymer refer to the strength and elongation of a film obtained by drying a thin layer of an aqueous dispersion in which a polymer is dispersed.
- An aqueous dispersion in which the following amount of polymer is dispersed is poured into a 5 cm X 5 cm polyethylene mold so as to have a thickness of about 0.5 mm, and at a predetermined temperature (50 ° C) for a predetermined time (room temperature 3 days) )
- the film obtained by drying is cut out with a No. 3 dumbbell, and the temperature is 20 ° C and the crosshead speed is 300 mmZmin.
- the present inventors have conducted intensive studies to solve the above problems, and as a result, have prepared a skin external preparation by blending a non-emulsifying cross-linkable silicone and a polyurethane that forms a film having a low shrinkage force.
- the inventors have found that the above-mentioned problems can be solved, and have completed the present invention.
- the present invention is not based on the conventional idea of using a powder or a shrinkable film, but instead of a paste-like material whose shape can be freely changed according to a wrinkle site and a film that does not shrink, "wrinkles".
- the present invention has been made based on the idea of “filling a film with a film”.
- a non-emulsifying cross-linkable silicone that can be deformed freely and a polyurethane as a film agent that does not shrink, a new mechanism for improving new wrinkles with superior functions is achieved by a different mechanism of action.
- An external preparation for skin was obtained.
- the present invention relates to (a) a non-emulsifying cross-linkable silicone, and (b) a film having a film formation shrinkage of 20% or less containing a polyurethane having a film shrinkage of 20% or less as a main component.
- a skin external preparation for improving wrinkles comprising a water-soluble polymer, (c) a liquid oil component, and (d) water.
- the film-forming polymer is a polymer that forms a film on the skin and the substrate when an aqueous dispersion of the polymer is applied to the skin and the substrate and dried.
- the non-emulsifiable crosslinkable silicone is a crosspolymer formed by the reaction of methylnitrogenpolysiloxane and methylvinylpolysiloxane, and a partially long-chain alkylated methylhydrido dienepolysiloxane and methylvinylpolysiloxane. Consists of crosspolymers by reaction and crosspolymers by reaction of methyl hydrogen polysiloxane with alkenes It is preferable that one or two or more selected from the group be used.
- the long-chain alkyl preferably has 10 to 14 carbon atoms.
- the non-emulsifiable cross-linked silicone is preferably blended with a swelled product swelled with a liquid oil.
- the polyurethane is preferably a polyurethane obtained by reacting an isocyanate compound with a diol compound containing a polyether diol, a polycarbonate diol, and a carboxyl group-containing alkylene diol. Preferably contains isophorone diisocyanate.
- the polyether diol is polytetramethylene glycol
- the polycarbonate diol is polyhexamethylene carbonate dial
- the carboxyl group-containing alkylene diol is dimethylolpropionic acid and Z or dimethylolbutanoic acid. It is preferable that
- the polyurethane preferably has a film strength of 300 to 700 kgZcm 2 .
- the film elongation of the polyurethane is preferably from 200 to 500%.
- the film shrinkage ratio containing a polyurethane having the film shrinkage ratio of 20% or less as a main component is 20%.
- % Or less of the film-forming polymer is preferably incorporated in an aqueous dispersion.
- the average particle size of the polyurethane in the aqueous polyurethane dispersion is preferably 10 to 300 nm.
- the polyurethane aqueous dispersion is composed of a mixture having an average particle size of 20 to 60 nm and an average particle size of 150 to 200 nm.
- the skin external preparation for improving wrinkles of the present invention comprises a non-emulsifiable cross-linked silicone in an amount of 0.5-5.0% by mass and a polyurethane having a film shrinkage of 20% or less in the total amount of the external preparation. It is preferred to contain 0.1 to 10.0 mass% in the total amount of the agent.
- the shrinking force in the present invention is a force for shrinking when an aqueous dispersion in which a polymer is dispersed forms a film, and the force is evaluated by a film forming shrinkage rate.
- the film formation shrinkage ratio is defined as the film formed by drying a thin layer of the aqueous dispersion in which the polymer is dispersed. It refers to the degree of shrinkage of a thin layer of the aqueous dispersion that shrinks.
- an aqueous dispersion in which a polymer in an amount of 1 g in terms of solid content is dispersed is poured into a 5 cm X 5 cm polyethylene mold so as to have a thickness of about 0.5 mm, and a predetermined temperature (50 ° C )),
- the length and width of the film obtained by drying for a predetermined time are measured and calculated according to the following formula.
- Deposition shrinkage (%) [(measured value in the vertical direction X measured value in the horizontal direction) / 25] X 100
- the film strength and film elongation of a polymer refer to the strength and elongation of a film obtained by drying a thin layer of an aqueous dispersion in which a polymer is dispersed.
- An aqueous dispersion in which the following amount of polymer is dispersed is poured into a 5 cm X 5 cm polyethylene mold so as to have a thickness of about 0.5 mm, and at a predetermined temperature (50 ° C) for a predetermined time (room temperature 3 days) )
- the film obtained by drying is cut out with a No. 3 dumbbell, and the temperature is 20 ° C and the crosshead speed is 300 mmZmin.
- the skin external preparation for improving wrinkles obtained by the present invention is non-greasy, while being soft, supple, resilient, flexible, and not easily cracked or peeled. It has a light feel without discomfort due to its good adhesion to the skin, it maintains good wearing comfort for a long time, and it can reliably remove fine wrinkles for a long period of time. It has the effect of improving wrinkles (which lasts).
- a skin external preparation for improving wrinkles that can increase the thickness of the film formed from the aqueous dispersion in which the polymer is dispersed, enhance and enhance the effect of improving wrinkles, and respond to skin elasticity and skin movement for a long time Can be obtained.
- the skin external preparation for wrinkle improvement of the present invention contains a polymer aqueous dispersion in which a water-insoluble film-forming polymer is dispersed in water, and the film-forming polymer has a film shrinkage rate of 20%. % Polyurethane or less and acrylic polymer whose film shrinkage is 20% or less. The film formation shrinkage is defined above.
- the preferred range of the film formation shrinkage is 10% or less.
- the lower limit of the film formation shrinkage is preferably 0, which does not shrink, but 5% is sufficient and practical. That is, the film formation shrinkage ratio in the present invention is 0 to 20%, and within the range, the preferable range of the combination of the upper limit and the lower limit, specifically, 5 to 20%, 0 to 10%, 5 to 10%, etc. Is used.
- an aqueous polyurethane dispersion in which a water-insoluble polyurethane is dispersed in water is used, and when the aqueous dispersion is applied to skin or a substrate and dried. Skin ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ Form a polyurethane film on the substrate.
- the polyurethane used in the present invention is a polymer having a urethane bond, and the urethane bond is generated by an addition reaction between an isocyanate group and a compound having active hydrogen such as a hydroxyl group.
- a polyurethane obtained by reacting at least (A) an isocyanate compound having two isoocyanate groups with (B) a diol compound having two hydroxy groups is preferable. ,.
- the isocyanate conjugate (component A) is not particularly limited as long as it is used in the production of ordinary polyurethane.
- aliphatic diisocyanate conjugates and alicyclic diisocyanate conjugates Organic diisocyanate conjugates such as conjugates and aromatic diisocyanate conjugates are preferred. More preferred are aliphatic diisocyanate conjugates and alicyclic diisocyanate conjugates.
- One or two or more isocyanate conjugates are arbitrarily selected and used.
- Examples of the aliphatic diisocyanate conjugate include, for example, ethylene diisocyanate, 2,2,4-trimethylhexamethylene diisocyanate, and 1,6-hexamethylene. And diisocyanate.
- Examples of the alicyclic diisocyanate conjugate include hydrogenated 4,4'-diphenyl methane diisocyanate, 1,4-cyclohexanediisocyanate, and methylcyclohexylene.
- aromatic diisocyanate conjugate examples include 4,4'-diphenylmethane diisocyanate, xylylene diisocyanate, toluene diisocyanate, naphthalenediisocyanate, and the like.
- 1,6xamethylene diisocyanate 1,6xamethylene diisocyanate, IPDI, norbornanediiso is excellent in weather resistance and easily available. Preference is given to cyanates and the like. In particular, IPDI is preferred.
- the diol compound (component B) is not particularly limited as long as it is used in the production of ordinary polyurethane.
- alkylene diol, carboxyl group-containing alkylene diol, alicyclic diol, spirodiol Preferred examples include polyester diol, polyether diol, polycarbonate diol, polybutadiene diol, polyisoprene diol, and polyolefin diol.
- alkylene diol, carboxyl group-containing alkylene diol, alicyclic diol, polyether diol and polycarbonate diol are more preferably used.
- One or more diol compounds are arbitrarily selected and used.
- alkylene diol examples include, for example, ethylene glycol, propylene glycol, 1,4-butanediol, 1,6-xanediol, neopentyl glycol, 1,8-octanediol, 1,10-decanediol and the like. No.
- carboxyl group-containing alkylene diol examples include carboxylic acids having a dialkylol group, such as dimethylol, diethanol, and dipropanol, having 3 to 26 carbon atoms, and preferably 3 to 12 carbon atoms.
- Specific examples include, for example, dimethylolpropionic acid (hereinafter, referred to as “DMPA”) and dimethylolbutanoic acid (hereinafter, referred to as “DMBA”). You may.
- CHDM 1,4-cyclohexanedimethanol
- spirodiol examples include, for example, spiroglycol and the like. I can get lost.
- polyester diol examples include, for example, at least one dicarboxylic acid such as succinic acid, glutaric acid, adipic acid, sebacic acid, azelaic acid, maleic acid, fumaric acid, phthalic acid, and terephthalic acid; Ethylene glycol, propylene glycol, 1,4-butanediol, 1,6-hexanediol, neopentyl glycol, 1,8-octanediol, 1,10-decanediol, diethylene glycol, polyethylene glycol (hereinafter referred to as “PEG”) ), Poly (propylene glycol) (hereinafter referred to as “PPG”), poly (ethylene glycol), polytetramethylene glycol, spiro glycol, and other diols obtained by condensation polymerization, and ring-opening polymerization of ratatonic acid. Obtained by the following method.
- dicarboxylic acid such as succ
- polyether diol examples include polyether diols contained in the diol used for the synthesis of the polyester diol.
- polyoxyethylene diols such as diethylene glycol and PEG
- polyoxy diols such as PPG Polyoxytetramethylenediol such as propylenediol and polytetramethylene glycol (hereinafter referred to as “PTMG”)
- PTMG Polyoxytetramethylenediol
- PO bisphenol A to propylene oxide
- EO ethylene oxide
- PEG, PPG and PTMG are preferred, and particularly PTMG is preferred in that it forms a soft film and has excellent adhesion to skin.
- polyhexamethylene carbonate diol (hereinafter, referred to as “PHMC”) forms a soft film, and has a point force such as excellent adhesion to skin.
- PHMC polyhexamethylene carbonate diol
- a polyurethane containing a carboxyl group when reacted by using a carboxyl group-containing alkylenediol as a diol compound, the By neutralizing the carboxyl group incorporated in the product with a neutralizing agent such as triethylamine, trimethylamine, 2-amino-2-methyl-1-propanol, triethanolamine, potassium hydroxide or sodium hydroxide.
- a neutralizing agent such as triethylamine, trimethylamine, 2-amino-2-methyl-1-propanol, triethanolamine, potassium hydroxide or sodium hydroxide.
- IPDI isocyanate compound
- a compound containing IPDI isocyanate compound
- a polyurethane having a structural unit derived from an alkylene oxide (RO) in the structure of the polyurethane whereby the elongation of a film obtained from an aqueous polyurethane dispersion is preferably used. It is easy to control the temperature to an appropriate value, and a flexible film can be formed.
- Examples of the compound having a structural unit derived from RO include, for example, diethylene glycol, polyoxyethylene diol such as PEG, polyoxypropylene diol such as PPG, polyoxytetramethylene diol such as PTMG, and polyoxyethylene.
- Polyoxypropylene glycol (EOZPO block copolymer) phenols such as bisphenol A, and bisphenol A obtained by ring-opening addition polymerization of at least one of PO and EO (in the case of a copolymer, a block copolymer, Any of random copolymers), and PEG, PPG, PTMG, etc. are preferably used.
- the compound having a structural unit derived from an RO force is the compound (B) described above. Used as a polyether diol component in the mixture.
- the aqueous polyurethane dispersion is produced by a conventional method. For example, a prepolymer containing the remaining isocyanate group obtained by reacting in an organic solvent is dispersed in water containing potassium hydroxide under high-speed stirring. Further, it can be obtained by conducting a chain lengthening reaction to increase the molecular weight, and recovering the organic solvent from the obtained aqueous liquid.
- the polyurethane and the aqueous polyurethane dispersion are more preferably as follows. That is,
- the strength is 300 to 700 kgZcm 2 , more preferably 400 to 6 OOkg / cm 2 . If the strength is less than 300 kg / cm 2 , it cannot withstand the movement of the skin and tends to peel off. In addition, when the weight exceeds 700 kgZcm 2 , the skin becomes uncomfortable. Further, the elongation is 200-500%, more preferably 300-500%. If the elongation is less than 200%, it is difficult to respond to the movement of the skin when a film is formed on the skin. On the other hand, if it exceeds 500%, the effect of improving wrinkles cannot be sufficiently obtained.
- the average particle size of the polyurethane in the aqueous polyurethane dispersion is 10 to 300 nm, more preferably 20 to 200 nm.
- the average particle size is less than 10 nm, the effect of improving fine wrinkles is sufficient, but the effect of improving large wrinkles is insufficient.
- the average particle size exceeds 300 nm, the adhesion to the skin tends to be poor and peeling tends to occur.
- aqueous polyurethane dispersions having different particle sizes.
- a wrinkle improving effect can be obtained, and a skin pattern erasing effect can be obtained.
- polyurethanes having different particle diameters polyurethanes having an average particle diameter of 20 to 60 nm and an average particle diameter of 150 to 200 nm are preferable.
- the content of the polyurethane is preferably 0.1 to 10% by mass based on the total amount of the external preparation for skin.
- the content is less than 0.1% by mass, the effect of the present invention cannot be sufficiently obtained, and if it exceeds 10% by mass, peeling of the skin tends to easily occur.
- a more preferred content is 118% by mass in the total amount of the external preparation for skin.
- an aqueous dispersion of an acrylic polymer in which an acrylic polymer insoluble in water is dispersed in water is used.
- the aqueous dispersion is applied to skin or a substrate, and dried.
- an acrylic polymer film is formed on the skin-substrate.
- Water dispersion As the product, it is preferable to use what is generally known as a polymer emulsion, for example, a polymer emulsion obtained by emulsion polymerization of an acrylic monomer.
- the acrylic polymer has a so-called film-forming property that forms a film on the skin or the substrate when the polymer emulsion is applied to the skin or the substrate and dried. Therefore, preferably, in the present invention, the acrylic polymer emulsion dispersed in water, that is, the force of diluting and blending the acrylic polymer emulsion itself may be used as an aqueous dispersion.
- a polymer of a monomer containing an acrylate ester monomer such as an acrylate ester and a methacrylate ester is preferable.
- the acrylate monomers include methyl acrylate, ethyl acrylate, propyl acrylate, n-butyl acrylate, tert-butyl acrylate, hexyl acrylate, cyclohexyl acrylate, acrylic Octyl acid, 2-ethylhexyl acrylate, methyl methacrylate, ethyl methacrylate, propyl methacrylate, n-butyl methacrylate, tert-butyl methacrylate, hexyl methacrylate, cyclohexyl methacrylate, methacrylic acid Octyl, 2-ethylhexyl methacrylate, and the like.
- the acrylate monomers are used alone or in combination
- hydrophobic monomers can be contained in addition to the acrylate monomer.
- hydrophobic monomer include aromatic mono- and divinyl conjugates such as styrene, ⁇ -methyl styrene, chlorostyrene, alkyl styrene, and divinyl benzene; fluorinated vinyl compounds such as acrylonitrile and metal phthalate; Butyl ester such as butyl; halogenated butyl such as butyl chloride, bilidene chloride; trifluoroethyl methacrylate, 2,2,3,3-tetrafluoropropyl methacrylate, 2,2,3 Examples include fluorine-based monomers such as 3,4,4-hexafluorobutyl methacrylate, norfluorooctyl methacrylate, perfluorooctyl acrylate, and silicone macromonomers.
- the acrylic polymer in the present invention is further copolymerized using a hydrophilic monomer.
- a stable polymer emulsion that is, a stable aqueous dispersion of an acrylic polymer can be obtained.
- hydrophilic monomer examples include ethylenically unsaturated carboxylic acids such as acrylic acid, methacrylic acid, itaconic acid, maleic acid, fumaric acid, crotonic acid, etc .; hydroxyethyl phthalate, hydroxyethyl methacrylate, glycidyl atari Hydroxy group-containing ethylenic monomers such as acrylate, glycidinolemethacrylate, ethylene glycol diatalylate, ethylene glycolone methacrylate, polyethylene glycolone methacrylate, and polyethylene glycol monomethacrylate; acrylamide, methacrylamide, N —Ethylenic amides such as methylol acrylamide, N methylol methacrylamide, N diacetone acrylamide; aminoethyl acrylate, aminoethyl methacrylate, N, N-dimethylamino Ruatalylate, N, N-dimethylamino Ruata
- a hydrophilic monomer having a carboxyl group in its structure is used as an acrylic polymer emulsion
- the carboxyl group incorporated in the molecule is neutralized with a neutralizing agent to produce an acrylic polymer emulsion.
- excellent dispersibility in water can be achieved.
- the neutralizing agent for the carboxyl group include triethylamine, trimethylamine, 2-amino-2-methyl-1 propanol, triethanolamine, rhodium hydroxide, sodium hydroxide, and the like.
- the monomer containing the acrylate monomer that produces the acrylic polymer according to the present invention may be used alone or in combination of two or more, and is selected from the above.
- hydrophobic monomer is 70 to 100 mole 0/0, preferably in the preferred gesture et al use a combination of hydrophilic monomer is 0 to 30 mole 0/0, the hydrophobic monomer is 85 to 99 mol%, the hydrophilic monomer 1 is a combination of one 15 mol 0/0.
- the acrylic polymer of the present invention is preferably a polymer (polymer) of a monomer mainly composed of an acrylic ester monomer composed of an acrylic ester and Z or a methacrylic ester. Further, a polymer of a monomer mainly containing ethyl acrylate and Z or ethyl methacrylate is preferred, and a monomer polymer mainly containing ethyl acrylate is preferred. [0084] Further, when a hydrophilic monomer is contained, the monomer is preferably acrylic acid and Z or methacrylic acid.
- the acrylic polymer emulsion used in the present invention preferably contains a sulfonated polyvinyl alcohol as an emulsifier and a protective colloid agent in order to impart a dense film-forming property.
- the polymerization is preferably carried out during the emulsion polymerization.
- the sulfonated polybutyl alcohol preferably used is represented by the following formula (2)
- the aqueous acrylic polymer dispersion of the present invention preferably contains a sulfonated polybutyl alcohol.
- surfactants to be used include, but are not particularly limited to, general ion-based, cationic or nonionic surfactants. Also, two or more kinds may be used in combination, such as a combination of an ion type and a nonionic type and a combination of a cationic type and a nonionic type. Among the above surfactants, nonionic surfactants are preferred.
- nonionic surfactant examples include polyoxyethylene (hereinafter, referred to as "POE") alkyl ether, POE alkylphenol ether, and POE-polypropylene oxide.
- POE polyoxyethylene
- aeon-based surfactant such as a block copolymer (hereinafter referred to as “POP”) include alkylbenzene sulfonate, alkylnaphthalene sulfonate, and polyethylene oxide alkyl ether sulfate.
- POP block copolymer
- examples of the cationic surfactant include primary, secondary, tertiary amine salts and quaternary ammonium salts having an aliphatic hydrocarbon group.
- Preferable nonionic surfactants are POE alkyl ethers, especially POE alkyl ethers having 12 to 20 carbon atoms, particularly POE oleyl ether.
- the number of moles of POE added is preferably 30 to 65 moles, particularly preferably 40 to 60 moles.
- the amount of the surfactant to be added is preferably 5 parts by mass or less, more preferably 3 parts by mass or less, based on 100 parts by mass of the monomer used. If the amount exceeds 5 parts by mass, the physical properties of the film will deteriorate.
- the acrylic polymer and the aqueous dispersion of an acrylic polymer are preferably the following. That is,
- the strength is 0.1 to 100 kgZcm 2 , more preferably 10 to 70 kgZcm 2 . If the strength is less than 0.1 kgZcm 2 , it cannot withstand the movement of the skin and tends to peel off. In addition, if it exceeds 100 kgZcm 2 , you will feel uncomfortable on the skin. Further, the elongation is 300-2000%, more preferably 500-1000%. If the elongation is less than 300%, it is difficult to respond to skin movement when a film is formed on the skin. If it exceeds 2000%, the effect of improving wrinkles cannot be sufficiently obtained. Also, the glass transition point (Tg) of the acryl polymer is preferably 0 ° C or less! /.
- the average particle size of the acrylic polymer in the acrylic polymer aqueous dispersion is 100 to 600 nm. If the average particle size is less than 100 nm, the effect of improving fine wrinkles is a sufficient force. On the other hand, the effect of improving large wrinkles is insufficient. On the other hand, if the average particle size exceeds 600 nm, the adhesiveness to the skin tends to be poor and peeling tends to occur.
- the content of the acrylic polymer is preferably 11 to 20% by mass based on the total amount of the external preparation for skin. If the content is less than 1% by mass, the effect of the present invention cannot be sufficiently obtained. On the other hand, if the content exceeds 20% by mass, the viscosity of the external preparation for skin becomes high, making it difficult to formulate and apply it to the skin. come. A more preferred content is 5 to 15% by mass of the total amount of the external preparation for skin.
- the film-forming polymer of the present invention is used as a main component, and is preferably composed of these polymers. On the condition that there are certain conditions, the addition of other film-forming polymers is not refused unless the effects of the present invention are impaired.
- the external preparation for skin of the present invention can further contain flaky silica, and this composition can enhance the effect of improving the wrinkles of the above-mentioned film composed of the polyurethane and the acrylic polymer. Specifically, the thickness of the film formed from the aqueous dispersion in which the polymer is dispersed is increased, the effect of wrinkle improvement is enhanced and strengthened, and wrinkle improvement that can respond to skin elasticity and skin movement over a long period of time External preparation for skin can be obtained.
- the flaky silica is a flaky silica particle having a self-forming property and capable of forming a strong film even at room temperature.
- Flake-like silica is a particle morphology.Layer flake-like silica, which is formed by laminating primary particles in parallel with each other with multiple planes. Have a.
- flaky silica a commercially available product can be used, and examples of the commercially available product include "Sanlaburi LFS-C" (manufactured by Dokai Iridakusha).
- the preferred content of the flaky silica in the present invention is 0.1 to 5.0% by mass, more preferably 0.5 to 3.0% by mass, based on the total amount of the external preparation for skin.
- the content is less than 0.1% by mass, the effect of adding the flaky silica cannot be sufficiently exerted.
- the content exceeds 5.0% by mass whiteness appears on the skin surface. It is visually pleasing.
- the skin external preparation of the present invention may contain, in addition to the components described above, other components usually used in cosmetics and pharmaceuticals, as long as the effects of the present invention are not impaired.
- the above-mentioned optional components are described in which the substances contained in the components may correspond to a plurality of components. Examples include oils, powder components other than the above, surfactants, humectants, and water-soluble polymers. , Thickeners, film-forming agents other than the present invention, ultraviolet absorbers, sequestering agents, sugars, amino acids, organic amines, PH regulators, skin nutrition, vitamins, antioxidants, fragrances Etc.
- the skin external preparation for improving wrinkles of the present invention can be prepared according to a conventional method by mixing the above components.
- the skin external preparation for improving wrinkles of the present invention is used by being formulated as creams, emulsions, lotions, and the like of basic cosmetics.
- Non-emulsifiable cross-linked silicone is a cross-linked silicone in which a part of a silicone chain is cross-linked and has no function of emulsifying oil and water.
- Non-emulsifiable means that when a composition containing a crosslinked silicone mixed with water and oil is stirred at high speed using a homomixer or the like, it is not emulsified, or even when emulsified, the emulsified particle size is 50 m or more. It can be confirmed that the emulsified state is not maintained when the emulsion is left for a while.
- the non-emulsifiable crosslinkable silicone used in the present invention includes, for example, a crosspolymer (hereinafter, referred to as a crosspolymer) obtained by reacting a diene polysiloxane having a methyl nodide with methyl vinyl polysiloxane.
- a crosspolymer obtained by reacting a diene polysiloxane having a methyl nodide with methyl vinyl polysiloxane.
- Dimethicone z-buldimethicone crosspolymer A cross-polymer obtained by the reaction of a partially long-chain alkylated methyl hydrogen polysiloxane and methyl vinyl polysiloxane (hereinafter referred to as a buldimethicone Z-alkyl dimethicone crosspolymer), and a reaction of methyl hydride polysiloxane with an alkene.
- Crosspolymer hereinafter, referred to as dimethicone crosspolymer
- methyl vinyl polysiloxane one having at least two vinyl groups in a molecule is used, and a crosspolymer is effectively produced in the present invention.
- methyl vinyl polysiloxane having one vinyl group in the molecule is used, and this plays a role in controlling the crosslinking rate of the crosspolymer.
- the carbon number of the long-chain alkyl of the partially long-chain alkylated methylhydrogenpolysiloxane can be arbitrarily set, but in the present invention, a lauryl group having a carbon number of 12, which is preferably 10 to 14 is preferred. Optimal.
- a lauryl group having a carbon number of 12, which is preferably 10 to 14 is preferred.
- the alkene one having at least two bull groups in the molecule is used, and a crosspolymer is effectively produced in the present invention.
- an alkene having one bullet group in the molecule is generally used for the formation, and this alkene plays a role in controlling the cross-linking rate of the crosspolymer.
- the dimethicone Z-buldimethicone crosspolymer corresponds to the one called INCI name dimethicone / buldimethicone crosspolymer or polysilicone 11.
- the dimethicone crosspolymer corresponds to what is referred to as INCI name dimethicone crosspolymer.
- the buldimethicone Z alkyl dimethicone crosspolymers the crosspolymer obtained by the reaction between laurylated methylhydrogenpolysiloxane and methylbilpolysiloxane (hereinafter referred to as buldimethicone Z lauryl dimethicone crosspolymer) is INCI name buldimethicone. This corresponds to what is called Z lauryl dimethicone crosspolymer.
- the content of the non-emulsifiable cross-linked silicone is preferably 0.5 to 5.0% by mass based on the total amount of the external preparation for skin. If the content is less than 0.5% by mass, the sufficient effect of the present invention cannot be obtained. If the content exceeds 5.0% by mass, the effect is not enhanced, and the effect is not so strong. Will occur.
- the liquid oil used in the present invention is not particularly limited as long as it is a liquid oil that can be mixed with a liquid cosmetic at normal temperature (25 ° C).
- the liquid oil component include liquid silicone oil, liquid hydrocarbon oil, liquid ester oil, and liquid higher fatty acids.
- liquid silicone oil examples include linear or cyclic silicone oils. Specific examples include dimethyl silicone, decamethylcyclopentasiloxane, otamethylcyclotetrasiloxane, phenyldimethicone, and octyltrisiloxane. Methicone and the like.
- liquid hydrocarbon oil examples include liquid paraffin, squalane, light isoparaffin, ⁇ -olefin oligomer, and isodecane.
- liquid ester oil examples include glyceryl tri-2-ethylhexanoate, diisobutyl adipic acid, di-2-ethylhexyl succinate, cetyl 2-ethylhexanoate, and 2-ethylhexanoic acid.
- liquid higher fatty acid examples include isostearic acid and the like.
- liquid oil component in the present invention is blended as one component forming the external preparation for skin of the present invention, and also functions as a swelling agent for the non-emulsifiable crosslinked silicone.
- liquid oil component in this case, a liquid oil component having a low viscosity at room temperature, for example, 100 mPa's or less is particularly preferable.
- the viscosity range is 1 lOOmPa ⁇ s.
- the mixing ratio of the non-emulsifiable cross-linked silicone and the liquid oil is 5 to 40: 9 in mass ratio. 5-60 is preferred. Within this range, a swelled product suitable for the skin external preparation of the present invention is obtained.
- the non-emulsifiable crosslinked silicone liquid oil swelled product is commercially available, and therefore, a commercially available product can be used.
- a commercially available product include the following.
- KSG-15 ((dimethicone Z buldimethicone) crosspolymer, a mixture of cyclopentasiloxane and about 5% of crosslinked product)
- KSG-16 ((Dimethicone Z- brieflyimethicone) crosspolymer, dimethicone 6mPa's mixture, about 25% cross-linked
- KS G-18 ((Dimethicone Z-Burdimethicone) Cross-polymer, Fe-trimethicone is a mixture of about 15% of cross-linked material)
- GRANSIL GCM Polysilicone 11 and Otatamethylcyclotetrasiloxane
- GRANSIL GCM-5 (about 6% of a mixture of Polysilicone 11 and decamethylcyclopentasilox
- KSG-41 ((Buldimethicone Z lauryl dimethicone) crosspolymer, a mixture of fluid paraffin and a crosslinked product of about 30%)
- KSG-42 ((Burdimethicone Z lauryl dimethicone) crosspolymer, a mixture of light isoparaffins with a cross-linked product of about 25%)
- KSG43 ((Burdimethicone Z lauryl dimethicone) crosspolymer, glyceryl tri-2-ethylhexanoate Cross-linked product is about 30% in the mixture
- KSG-44 ((Burdimethicone Z lauryl dimethicone) crosspolymer; cross-linked product is about 5% in the mixture of squalane) (all manufactured by Shin-Etsu Chemical Co
- DC9040 a mixture of dimethicone crosspolymer and decamethylcyclopentasiloxane with a crosslinked product of 12%
- DC9041 dimethicone 5 mPa's
- DC9045 a mixture of dimethicone crosspolymer and decamethylcyclopentasiloxane, and 12.5% of a crosslinked product
- the content of the liquid oil component is preferably 0.5 to 30.0% by mass based on the total amount of the external preparation for skin. When the content is within this range, a sufficient effect of the present invention can be obtained.
- the skin external preparation for wrinkle improvement of the present invention further comprises a water-insoluble film shrinkage as an essential component.
- the film-forming polymer contains a polyurethane having a film-forming shrinkage of 20% or less as a main component. Note that the film formation shrinkage rate is defined above.
- the film-forming polymer has a polyurethane force of 20% or less in film-forming shrinkage.
- the film-forming shrinkage of all the film-forming polymers is 20% or less, the addition of other film-forming polymers is not refused as long as the effects of the present invention are not impaired.
- the film shrinkage exceeds 20%, the effect of the present invention such as peeling on the skin where the effect of improving wrinkles is weak, "shininess" becomes conspicuous, and there is a sense of incongruity in usability is also considered. It cannot be demonstrated.
- the preferred range of the film formation shrinkage is 10% or less.
- the lower limit of the film formation shrinkage is preferably 0, which does not shrink, but 5% is sufficient and is industrially practical. That is, the film formation shrinkage ratio in the present invention is 0 to 20%, and within the range, the combination of the above preferable upper limit and lower limit, specifically 5 to 20%, 0 to 10%, and 5 to 10% Etc. are used.
- the polyurethane used in the present invention is a polymer having a urethane bond, and the urethane bond is generated by an addition reaction between an isocyanate group and a compound having active hydrogen such as a hydroxyl group.
- a polyurethane obtained by reacting at least (A) an isocyanate compound containing two isoocyanate groups with (B) a diol compound containing two hydroxyl groups is preferable. ,.
- the isocyanate conjugate (Component A) is not particularly limited as long as it is used in the production of ordinary polyurethane.
- aliphatic diisocyanate conjugates and alicyclic diisocyanate conjugates Organic diisocyanate conjugates such as conjugates and aromatic diisocyanate conjugates are preferred. More preferred are aliphatic diisocyanate conjugates and alicyclic diisocyanate conjugates.
- One or two or more isocyanate conjugates are arbitrarily selected and used.
- Examples of the aliphatic diisocyanate conjugate include, for example, ethylene diisocyanate, 2,2,4-trimethylhexamethylene diisocyanate, 1,6-hexamethylene And diisocyanate.
- Examples of the alicyclic diisocyanate conjugate include hydrogenated 4,4′-diphenyl methane diisocyanate, 1,4-cyclohexanediisocyanate, and methylcyclohexylene diisocyanate.
- IPDI Isophorone diisocyanate
- norbornane diisocyanate norbornane diisocyanate
- aromatic diisocyanate conjugate examples include 4,4'-diphenylmethane diisocyanate, xylylene diisocyanate, toluene diisocyanate, naphthalenediisocyanate and the like.
- 1,6 xamethylene diisocyanate 1,6 xamethylene diisocyanate, IPDI, norbornane diiso- ate is excellent in weather resistance and easily available. Preference is given to cyanates and the like. In particular, IPDI is preferred.
- the diol compound (component B) is not particularly limited as long as it is used in the production of ordinary polyurethane.
- alkylene diol, alkylene diol containing carboxyl group, alicyclic diol, spirodiol Preferred examples include polyester diol, polyether diol, polycarbonate diol, polybutadiene diol, polyisoprene diol, and polyolefin diol.
- alkylene diol, carboxyl group-containing alkylene diol, alicyclic diol, polyether diol and polycarbonate diol are more preferably used.
- One or more diol compounds are arbitrarily selected and used.
- alkylene diol examples include, for example, ethylene glycol, propylene glycol, 1,4-butanediol, 1,6-xanediol, neopentyl glycol, 1,8-octanediol, 1,10-decanediol, and the like. No.
- Suitable examples of the carboxyl group-containing alkylene diol include carboxylic acids having a dialkylol group, such as dimethylol, diethanol, and dipropanol, having 3 to 26 carbon atoms, and preferably 3 to 12 carbon atoms.
- Specific examples include, for example, dimethylolpropionic acid (hereinafter, referred to as “DMPA”) and dimethylolbutanoic acid (hereinafter, referred to as “DMBA”). You may.
- a polyurethane containing a carboxyl group when reacted by using a carboxyl group-containing alkylenediol as a diol compound, the By neutralizing the carboxyl group incorporated in the product with a neutralizing agent such as triethylamine, trimethylamine, 2-amino-2-methyl-1-propanol, triethanolamine, potassium hydroxide or sodium hydroxide.
- a neutralizing agent such as triethylamine, trimethylamine, 2-amino-2-methyl-1-propanol, triethanolamine, potassium hydroxide or sodium hydroxide.
- CHDM 1,4-cyclohexanedimethanol
- Preferred examples of the spirodiol include, for example, spiroglycol and the like.
- polyester diol examples include, for example, at least one dicarboxylic acid such as succinic acid, glutaric acid, adipic acid, sebacic acid, azelaic acid, maleic acid, fumaric acid, phthalic acid, and terephthalic acid; Ethylene glycol, propylene glycol, 1,4-butanediol, 1,6-hexanediol, neopentyl glycol, 1,8-octanediol, 1,10-decanediol, diethylene glycol, polyethylene glycol (hereinafter referred to as “PEG”) ), Poly (propylene glycol) (hereinafter referred to as “PPG”), poly (ethylene glycol), polytetramethylene glycol, spiro glycol, and other diols obtained by condensation polymerization, and ring-opening polymerization of ratatonic acid. Obtained by the following method.
- dicarboxylic acid such as succ
- polyether diol examples include polyether diols contained in the diol used in the synthesis of the polyester diol. Examples thereof include polyoxyethylene diols such as diethylene glycol and PEG, and polyoxy diols such as PPG. Polyoxytetramethylenediol such as propylenediol and polytetramethylene glycol (hereinafter referred to as “PTMG”), phenols such as bisphenol A, and bisphenol A to propylene oxide (hereinafter referred to as “PO”).
- PTMG propylenediol and polytetramethylene glycol
- PO bisphenol A to propylene oxide
- EO ethylene oxide
- PEG, PPG and PTMG are preferred, and particularly PTMG is preferred in that it forms a soft film and has excellent adhesion to skin.
- Preferred examples of the polycarbonate diol include, for example, polyhexamethylene carbonate diol (hereinafter referred to as “PHMC”), which forms a soft film and has excellent adhesion to skin, etc.
- PHMC polyhexamethylene carbonate diol
- the diol compound component B
- a mixture of polyether diol, polycarbonate diol, and carboxyl group-containing alkylene diol component B
- an excellent wrinkle-reducing effect is exhibited. It is preferable because a polyurethane that forms a film can be obtained.
- IPDI isocyanate disulfide
- IPDI isocyanate diversion
- a polyurethane having a structural unit derived from an alkylene oxide hereinafter referred to as "RO"
- RO alkylene oxide
- Examples of the compound having a structural unit derived from RO include, for example, diethylene glycol, polyoxyethylene diol such as PEG, polyoxypropylene diol such as PPG, polyoxytetramethylene diol such as PTMG, polyoxyethylene Polyoxypropyl Phenols such as lenglycol (EOZPO block copolymer) and bisphenol A, and those obtained by ring-opening addition polymerization of bisphenol A with at least one of PO and EO (for copolymers, block copolymers and random copolymers) And PEG, PPG, PTMG and the like are preferably used.
- the compound having a structural unit capable of inducing RO force is used as a polyether diol component in the component (B).
- the aqueous dispersion is applied to the skin and forms a polymer film on the skin when dried.
- the film-forming polymer according to the present invention is used.
- the aqueous polyurethane dispersion is produced by a conventional method.
- a prepolymer having residual isocyanate groups obtained by reaction in an organic solvent is dispersed in water containing potassium hydroxide under high-speed stirring, Further, it can be obtained by conducting a chain lengthening reaction to increase the molecular weight, and recovering the organic solvent from the obtained aqueous liquid.
- the following are further preferable for the polyurethane and the aqueous polyurethane dispersion. That is,
- the strength is 300- 700kgZcm 2, more preferably 400- 6 00kg / cm 2. If the strength is less than 300 kg / cm 2 , it cannot withstand the movement of the skin and tends to peel off. In addition, if the weight exceeds 700 kg / cm 2 , the skin becomes uncomfortable. Further, the elongation is 200-500%, more preferably 300-500%. If the elongation is less than 200%, it is difficult to respond to the movement of the skin when a film is formed on the skin. On the other hand, if it exceeds 500%, the effect of improving wrinkles cannot be sufficiently obtained.
- the average particle size of the polyurethane in the aqueous polyurethane dispersion is from 10 to 300 nm, more preferably from 20 to 200 nm.
- the average particle size is less than 10 nm, the effect of improving fine wrinkles is sufficient, but the effect of improving large wrinkles is insufficient.
- the average particle size exceeds 300 nm, the adhesion to the skin tends to be poor and peeling tends to occur.
- polyurethane aqueous dispersions having different particle sizes. It is a mode that is not good. As a result, a wrinkle improving effect can be obtained, and a skin pattern erasing effect can be obtained.
- polyurethanes having different particle diameters polyurethanes having an average particle diameter of 20 to 60 nm and an average particle diameter of 150 to 200 nm are preferable.
- the prepolymer After cooling the prepolymer remaining with the isocyanate groups to 50 ° C, the prepolymer was dispersed in 800 g of water containing 6 g of potassium hydroxide under high-speed stirring, and further subjected to a chain extension reaction at 50 ° C for 3 hours. The molecular weight was increased. The above ethyl acetate was recovered from the obtained aqueous liquid to obtain an aqueous polyurethane dispersion substantially containing a solvent (solid content of polyurethane: 20% by mass).
- the prepolymer having the isocyanate groups remaining to 50 ° C was dispersed in 700 g of water containing 6 g of potassium hydroxide under high-speed stirring, and a chain extension reaction was performed at 50 ° C for 3 hours. To increase the molecular weight. The ethyl acetate was recovered from the resulting aqueous liquid to obtain a polyurethane aqueous dispersion substantially free of solvent (polyurethane solid content: 20% by mass).
- the content of the polyurethane having a film formation shrinkage of 20% or less in the present invention is preferably 0.1 to 10.0 mass% in the total amount of the external preparation for skin. If the content is less than 0.1% by mass, the effect of the present invention is not sufficiently obtained. On the other hand, if the content exceeds 10.0% by mass, the skin force tends to easily peel off. A more preferred content is 1.0-8.0% by mass in the total amount of the external preparation for skin.
- the external preparation for skin of the present invention does not refuse to blend other film-forming polymers other than polyurethane having a film formation shrinkage of 20% or less as described above. And the like.
- the content of all the film-forming polymers is 0.1 to 10. It is preferably in the range of 0% by mass.
- Another essential component of the present invention is water. Water is further appropriately compounded in addition to the water contained in the other essential components to form a skin external preparation.
- the skin external preparation of the present invention may contain other components that are commonly used in cosmetics, pharmaceuticals, and the like as long as the effects of the present invention are not impaired.
- the description of the optional components is partially overlapping, for example, other oil components, powder components, surfactants, humectants, water-soluble polymers, thickeners, ultraviolet absorbers, sequestering metals Agents, sugars, amino acids, organic amines, PH regulator, skin nutrition, vitamins, antioxidants, fragrances and the like.
- the skin external preparation for wrinkle improvement of the present invention can be prepared according to a conventional method by blending the above components.
- the skin external preparation for improving wrinkles of the present invention is formulated and used as a cream, an emulsion, a lotion, a jewel or the like of a basic cosmetics.
- the prepolymer having the isocyanate groups remaining to 50 ° C was dispersed in 800 g of water containing 6 g of potassium hydroxide under high-speed stirring, and further subjected to a chain extension reaction at 50 ° C for 3 hours. The molecular weight was increased. The above ethyl acetate was recovered from the obtained aqueous liquid to obtain an aqueous polyurethane dispersion substantially containing a solvent (solid content of polyurethane: 20% by mass).
- the prepolymer having the isocyanate groups remaining to 50 ° C was dispersed in 700 g of water containing 6 g of potassium hydroxide under high-speed stirring, and a chain extension reaction was performed at 50 ° C for 3 hours. To increase the molecular weight. The ethyl acetate was recovered from the resulting aqueous liquid to obtain a polyurethane aqueous dispersion substantially free of solvent (polyurethane solid content: 20% by mass).
- a monomer consisting of 40 g of ion-exchanged water, sodium lg of lauryl sulfate, 1 g of polyoxyethylene cetyl ether, 50 g of methyl methacrylate, 42 g of 2-ethylhexyl acrylate, 3 g of methacrylic acid, and 1.4 g of sulfonated polybutyl alcohol Mixed solution And an aqueous initiator solution containing 0.3 parts of potassium persulfate and 10 parts of ion-exchanged water.
- the monomer mixture solution and the remainder of the initiator aqueous solution are simultaneously removed by about The mixture was dropped into a four-necked flask over 3 hours. After stirring for 1 hour while maintaining the liquid temperature at 80 ° C, the obtained reaction mixture was cooled to 50 ° C. Thereafter, the pH was adjusted to about 8 by adding ammonia water, and then cooled to room temperature to obtain a target acrylic polymer aqueous dispersion (acrylic polymer solid content: 50% by mass).
- the monomer mixture solution and the remainder of the initiator aqueous solution are respectively removed.
- the mixture was dropped into a four-necked flask over a period of about 3 hours to prepare the mixture.
- the obtained reaction mixture was cooled to 50 ° C.
- the pH was adjusted to about 8 by adding ammonia water, and the mixture was cooled to room temperature to obtain a target acrylic polymer aqueous dispersion (acrylic polymer solid content: 50% by mass).
- aqueous dispersion containing a polymer (polyurethane, acrylic polymer, etc.) in an amount equivalent to lg of solids was dispersed on a 5 cm x 5 cm polyethylene mold to a film thickness of about 0.5 mm.
- the film was poured and dried at a predetermined temperature (50 ° C.) for a predetermined time (room temperature for 3 days), and the length and width of the film obtained were measured, and the film formation shrinkage (%) was calculated according to the following equation.
- Deposition shrinkage (%) [(longitudinal measured value x lateral measured value) / 25] X 100
- An aqueous dispersion of a polymer (polyurethane, acrylic polymer, etc.) in an amount of lg on a solid basis is poured onto a 5 cm ⁇ 5 cm polyethylene mold so as to have a thickness of about 0.5 mm, and a predetermined temperature (50 ° C.)
- the film obtained by drying at a predetermined time was die-cut with a No. 3 dumbbell and subjected to a test.
- the strength and elongation were measured under the conditions of a temperature of 20 ° C and a crosshead speed of 300 mmZmin using an autograph of “Tensile tester RTM-250” manufactured by Orientic.
- the aqueous dispersion of the polymer was measured with a laser light scattering particle size distribution analyzer manufactured by Otsuka Electronics Co., Ltd.
- the compounding amount is mass%. Prior to the description of the examples, the effect test method used in the present invention will be described.
- a skin external preparation for improving wrinkles having the components and the amounts shown in Tables 11 to 13 (total amount of 100% by mass) was prepared by mixing the respective components.
- an effect test was performed on the wrinkle-improving skin external preparation of Example 1-1-1-1-13 and Comparative Example 11--19, and the evaluation results were combined. The results are shown in Table 1-1-1-3.
- Aqueous silica dispersion (solid content 1 10.0 10.0 4.0 20.0 5% by mass) (Note 6)
- the wrinkle improving skin external preparation of Example 1-13 according to the present invention is excellent in the effect of improving wrinkles, peeling, shininess, stickiness, You can see that there is no discomfort.
- none of the skin external preparations for wrinkle improvement of Comparative Example 119 which did not satisfy the constitutional requirements of the present invention could not exhibit the effects of the present invention.
- the compounding amount is mass%. Prior to the description of the examples, a method for evaluating and measuring a film used in the present invention and a method for testing an effect will be described.
- An aqueous dispersion of the polymer in an amount equivalent to the solid equivalent lg is poured onto a polyethylene mold of 5 cm x 5 cm so as to have a film thickness of about 0.5 mm, and the mixture is heated at a predetermined temperature (50 ° C) for a predetermined time (room temperature).
- the film obtained by drying for 3 days was die-cut with a No. 3 dumbbell and subjected to a test.
- the strength and elongation were measured at the temperature of 20 ° C and the crosshead speed of 300 mmZmin using the autograph of “Tension Tester RTM-250” manufactured by Orientic Co., Ltd. o
- Table 2-1 The skin external preparation for improving wrinkles having the formulation and the blending amount shown in Table 1-1 (total blending amount: 100% by mass) was prepared by mixing the respective components.
- total blending amount: 100% by mass was prepared by mixing the respective components.
- KF7312J decamethylcyclopentasiloxane solution; effective component 50%
- Example 2-1 according to the present invention (1) It can be seen that the skin external preparation for wrinkle improvement of 2-8 is excellent in wrinkle improvement effect and does not have peeling, shininess, sticky feeling and uncomfortable feeling. On the other hand, the skin external preparation for wrinkle improvement of Comparative Examples 2-1 to 2-11 which does not satisfy the constitutional requirements of the present invention was such that the effect of the present invention could not be exhibited even if the deviation was obtained.
- KSG-16 solid content about 25% (manufactured by Shin-Etsu Chemical Co., Ltd.)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Cosmetics (AREA)
Abstract
Description
Claims
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/584,171 US20070148120A1 (en) | 2004-01-14 | 2005-01-14 | Skin preparations for external use for wrinkle reduction |
CN2005800022368A CN1909882B (zh) | 2004-01-14 | 2005-01-14 | 用于改善皱纹的皮肤外用剂 |
EP05703571A EP1704849A4 (en) | 2004-01-14 | 2005-01-14 | DERMAL PREPARATIONS FOR EXTERNAL USE, INTENDED TO DECREASE WRINKLES |
KR1020067006970A KR101101363B1 (ko) | 2004-01-14 | 2005-01-14 | 주름개선용 피부외용제 |
HK07105149.2A HK1098688A1 (en) | 2004-01-14 | 2007-05-15 | Skin preparations for external use for wrinkle diminution |
US12/690,117 US20100119470A1 (en) | 2004-01-14 | 2010-01-20 | Method Of Reducing The Appearance Of Wrinkles |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004-006285 | 2004-01-14 | ||
JP2004006285A JP4590186B2 (ja) | 2004-01-14 | 2004-01-14 | しわ改善用皮膚外用剤 |
JP2004-245079 | 2004-08-25 | ||
JP2004245079A JP2006062995A (ja) | 2004-08-25 | 2004-08-25 | しわ改善用皮膚外用剤 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/690,117 Division US20100119470A1 (en) | 2004-01-14 | 2010-01-20 | Method Of Reducing The Appearance Of Wrinkles |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2005067884A1 true WO2005067884A1 (ja) | 2005-07-28 |
Family
ID=34797730
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2005/000332 WO2005067884A1 (ja) | 2004-01-14 | 2005-01-14 | しわ改善用皮膚外用剤 |
Country Status (6)
Country | Link |
---|---|
US (2) | US20070148120A1 (ja) |
EP (1) | EP1704849A4 (ja) |
KR (1) | KR101101363B1 (ja) |
HK (1) | HK1098688A1 (ja) |
TW (1) | TW200526262A (ja) |
WO (1) | WO2005067884A1 (ja) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007057448A1 (en) | 2005-11-21 | 2007-05-24 | L'oréal | Topical compositions for promoting homeostasis of the skin |
CN101516327A (zh) * | 2006-09-25 | 2009-08-26 | 纳幕尔杜邦公司 | 化妆品组合物 |
US10933010B2 (en) | 2015-05-11 | 2021-03-02 | Hayashibara Co., Ltd. | External dermal agent |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7879942B2 (en) | 2006-10-05 | 2011-02-01 | Eastman Chemical Company | Switchable adhesive article for attachment to skin and method of using the same |
JP4450427B2 (ja) * | 2007-11-13 | 2010-04-14 | 株式会社資生堂 | 皮膚化粧料 |
FR2924022B1 (fr) * | 2007-11-23 | 2009-12-04 | Oreal | Composition cosmetique tenseur |
EP2105125A1 (de) * | 2008-03-26 | 2009-09-30 | Bayer MaterialScience AG | Hautpflege-Zusammensetzung |
EP2141181B1 (en) | 2008-07-03 | 2012-05-02 | Rohm and Haas Company | Leather Coating Compositions Having Improved Embossability |
JP2012515063A (ja) * | 2009-01-16 | 2012-07-05 | ザ プロクター アンド ギャンブル カンパニー | 角質表面を改質するための装置及び方法 |
EP2382965B1 (en) * | 2009-01-28 | 2018-03-07 | Naoko Iwagaki | Solution for forming double eyelid and method for forming double eyelid using same |
JP2012020989A (ja) * | 2010-06-17 | 2012-02-02 | Shiseido Co Ltd | 肌改善皮膚化粧料 |
KR101044853B1 (ko) * | 2010-07-06 | 2011-06-28 | 최광석 | 수성 네일 래커 조성물 |
JP5547123B2 (ja) * | 2011-03-30 | 2014-07-09 | 株式会社 資生堂 | 油中水型乳化化粧料 |
EP2754694A4 (en) * | 2011-12-09 | 2015-05-06 | Dainippon Ink & Chemicals | FILMOGENIC AUXILIARY, AQUEOUS RESIN COMPOSITION AND SURFACE TREATMENT AGENT OF A STEEL SHEET CONTAINING THE SAME |
US10156036B2 (en) | 2014-06-13 | 2018-12-18 | The Procter & Gamble Company | Device and methods for applying compositions to fabric surfaces |
WO2015191830A2 (en) | 2014-06-13 | 2015-12-17 | The Procter & Gamble Company | Treatment compositions, apparatus and methods for modifying keratinous surfaces |
US10188192B2 (en) | 2014-06-13 | 2019-01-29 | The Procter & Gamble Company | Apparatus and methods for modifying keratinous surfaces |
US20160114349A1 (en) | 2014-06-13 | 2016-04-28 | The Procter & Gamble Company | Device and methods for depositing materials on hard surfaces |
KR101988846B1 (ko) | 2014-06-13 | 2019-06-13 | 더 프록터 앤드 갬블 캄파니 | 각질 표면 상의 처리 조성물의 침착을 위한 카트리지 |
US10518291B2 (en) | 2014-06-13 | 2019-12-31 | The Procter & Gamble Company | Device and methods for modifying surfaces |
US9924875B2 (en) | 2014-06-13 | 2018-03-27 | The Procter & Gamble Company | Apparatus and methods for modifying keratinous surfaces |
CA3024544C (en) | 2014-06-13 | 2020-06-23 | The Procter & Gamble Company | Apparatus and methods for modifying keratinous surfaces |
CA2949129C (en) | 2014-06-13 | 2020-06-30 | The Procter & Gamble Company | Apparatus and methods for modifying keratinous surfaces |
US10314378B2 (en) | 2014-07-25 | 2019-06-11 | The Procter & Gamble Company | Cartridge assembly for a dispensing device |
US9955769B2 (en) | 2014-07-25 | 2018-05-01 | The Procter & Gamble Company | Applicator heads for handheld treatment apparatus for modifying keratinous surfaces |
US11083880B2 (en) | 2014-07-25 | 2021-08-10 | The Procter & Gamble Company | Angled cartridge assembly for a dispensing device |
US9949552B2 (en) | 2014-07-25 | 2018-04-24 | The Procter & Gamble Company | Handheld treatment apparatus for modifying keratinous surfaces |
US10188193B2 (en) | 2014-07-25 | 2019-01-29 | The Procter & Gamble Company | Applicator heads for handheld treatment apparatus for modifying keratinous surfaces |
US9962532B2 (en) | 2015-06-11 | 2018-05-08 | The Procter & Gamble Company | Cartridges for use in an apparatus for modifying keratinous surfaces |
US11116302B2 (en) | 2015-06-11 | 2021-09-14 | The Procter & Gamble Company | Apparatus and methods for modifying keratinous surfaces |
US9949547B2 (en) | 2015-06-11 | 2018-04-24 | The Procter & Gamble Company | Cartridges for use in an apparatus for modifying keratinous surfaces |
US10166799B2 (en) | 2015-12-07 | 2019-01-01 | The Procter & Gamble Company | Service stations for handheld fluid jet apparatuses |
US9616668B1 (en) | 2015-12-07 | 2017-04-11 | The Procter & Gamble Company | Servicing cassettes for handheld fluid jet apparatuses for use in modifying surfaces |
US10391042B2 (en) | 2015-12-07 | 2019-08-27 | The Procter & Gamble Company | Treatment compositions, apparatus and methods for modifying keratinous surfaces |
WO2018179390A1 (ja) * | 2017-03-31 | 2018-10-04 | 株式会社コーセー | ポリウレタンゲル組成物及びその利用 |
US11090238B2 (en) | 2017-06-16 | 2021-08-17 | The Procter & Gamble Company | Array of cosmetic compositions for camouflaging tonal imperfections |
JP6931404B2 (ja) | 2017-06-16 | 2021-09-01 | ザ プロクター アンド ギャンブル カンパニーThe Procter & Gamble Company | 可聴フィードバックを有するパーソナルケアデバイス |
CA3064495C (en) | 2017-06-16 | 2022-08-30 | The Procter & Gamble Company | Computer asissted colorimetric make up method for camouflaging skin color deviations |
WO2023102287A1 (en) | 2021-12-03 | 2023-06-08 | The Procter & Gamble Company | Personal care device with audible feedback |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0687720A (ja) * | 1992-09-08 | 1994-03-29 | Nippon Sheet Glass Co Ltd | 鱗片状のシリカを配合した化粧料 |
JPH11504949A (ja) * | 1997-01-03 | 1999-05-11 | ロレアル | ポリマー系の水性分散物を含む化粧品及び/又は皮膚科学的組成物と、伸張剤としてのこの系の使用 |
JPH11507396A (ja) * | 1996-03-04 | 1999-06-29 | ロレアル | 重合システムを含有する組成物および前記システムの用途 |
JP2001294510A (ja) * | 2000-03-21 | 2001-10-23 | Avon Products Inc | 皮膚の容貌を増進する方法及びこのための局所用組成物 |
JP2003321326A (ja) * | 2002-04-12 | 2003-11-11 | L'oreal Sa | テンション剤を含む多層エマルジョンの形態の化粧品組成物 |
JP2004161771A (ja) * | 2002-11-12 | 2004-06-10 | L'oreal Sa | テンショニングラテックスとイオン性両親媒性ポリマーとを含む組成物、特に化粧品組成物 |
JP2004168667A (ja) * | 2002-11-18 | 2004-06-17 | Dokai Chemical Industries Co Ltd | シリカ配合化粧料 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS515871B2 (ja) * | 1973-01-19 | 1976-02-23 | Nippon Synthetic Chem Ind | |
CA1080627A (en) * | 1976-02-02 | 1980-07-01 | Albert Shansky | Liquid nail polish including dissolved polyamide |
LU84210A1 (fr) * | 1982-06-17 | 1984-03-07 | Oreal | Composition a base de polymeres cationiques,de polymeres anioniques et de cires destinee a etre utilisee en cosmetique |
DE3333723A1 (de) * | 1983-09-17 | 1985-04-04 | Bayer Ag, 5090 Leverkusen | Kerbschlagzaehe, in der schmelze leichtfliessende polyamide |
US4777041A (en) * | 1986-08-07 | 1988-10-11 | Charles Of The Ritz Group Ltd. | Wrinkle treatment formulation |
TW349984B (en) * | 1993-09-13 | 1999-01-11 | Starck H C Gmbh Co Kg | Pastes for the coating of substrates, methods for manufacturing them and their use |
ES2237758T3 (es) * | 1994-11-30 | 2005-08-01 | Chevron Phillips Chemical Company Lp | Resinas de polimeros estirenicos con brillo y resistencia al impacto mejorados. |
FR2743297B1 (fr) * | 1996-01-05 | 1998-03-13 | Oreal | Composition cosmetiques a base de polycondensats ionisables multisequences polysiloxane/polyurethane et/ou polyuree en solution et utilisation |
US5736128A (en) * | 1996-05-14 | 1998-04-07 | Isp Investments Inc. | Cosmetic composition for rejuvenation of skin without skin irritation |
JP3795671B2 (ja) * | 1998-05-29 | 2006-07-12 | 旭硝子エスアイテック株式会社 | シリカ−金属酸化物微粒子複合体を配合した化粧料 |
FR2789306A1 (fr) * | 1999-02-05 | 2000-08-11 | Oreal | Composition cosmetique comprenant un poly(hydroxystyrene) dans un milieu aqueux |
GB9909711D0 (en) * | 1999-04-27 | 1999-06-23 | Unilever Plc | Mousse forming hair treatment composition |
US6534176B2 (en) * | 1999-12-10 | 2003-03-18 | Asahi Glass Company, Limited | Scaly silica particles and hardenable composition containing them |
WO2002015874A2 (en) * | 2000-08-22 | 2002-02-28 | The Procter & Gamble Company | Personal care compositions containing anionic film-forming polymer and adhesive elastomeric polymer |
KR100467113B1 (ko) * | 2001-01-31 | 2005-01-24 | 가부시키가이샤 구라레 | 수성 수지 조성물 및 이 조성물을 사용한 면상 파스너의제조방법 |
FR2832058A1 (fr) * | 2001-11-15 | 2003-05-16 | Oreal | Eye-liner comprenant un polyurethane |
DE20207329U1 (de) * | 2002-05-10 | 2002-10-24 | Schwan Stabilo Cosmetics Gmbh | Zubereitung |
US7993632B2 (en) * | 2002-12-20 | 2011-08-09 | L'oreal S.A. | Composition for coating keratin fibres having a threading nature |
WO2006136720A1 (fr) * | 2005-06-22 | 2006-12-28 | L'oreal | Compositions de maquillage des matieres keratiniques |
-
2005
- 2005-01-11 TW TW094100692A patent/TW200526262A/zh not_active IP Right Cessation
- 2005-01-14 US US10/584,171 patent/US20070148120A1/en not_active Abandoned
- 2005-01-14 EP EP05703571A patent/EP1704849A4/en not_active Withdrawn
- 2005-01-14 WO PCT/JP2005/000332 patent/WO2005067884A1/ja not_active Application Discontinuation
- 2005-01-14 KR KR1020067006970A patent/KR101101363B1/ko active IP Right Grant
-
2007
- 2007-05-15 HK HK07105149.2A patent/HK1098688A1/xx not_active IP Right Cessation
-
2010
- 2010-01-20 US US12/690,117 patent/US20100119470A1/en not_active Abandoned
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0687720A (ja) * | 1992-09-08 | 1994-03-29 | Nippon Sheet Glass Co Ltd | 鱗片状のシリカを配合した化粧料 |
JPH11507396A (ja) * | 1996-03-04 | 1999-06-29 | ロレアル | 重合システムを含有する組成物および前記システムの用途 |
JPH11504949A (ja) * | 1997-01-03 | 1999-05-11 | ロレアル | ポリマー系の水性分散物を含む化粧品及び/又は皮膚科学的組成物と、伸張剤としてのこの系の使用 |
JP2001294510A (ja) * | 2000-03-21 | 2001-10-23 | Avon Products Inc | 皮膚の容貌を増進する方法及びこのための局所用組成物 |
JP2003321326A (ja) * | 2002-04-12 | 2003-11-11 | L'oreal Sa | テンション剤を含む多層エマルジョンの形態の化粧品組成物 |
JP2004161771A (ja) * | 2002-11-12 | 2004-06-10 | L'oreal Sa | テンショニングラテックスとイオン性両親媒性ポリマーとを含む組成物、特に化粧品組成物 |
JP2004168667A (ja) * | 2002-11-18 | 2004-06-17 | Dokai Chemical Industries Co Ltd | シリカ配合化粧料 |
Non-Patent Citations (1)
Title |
---|
See also references of EP1704849A4 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007057448A1 (en) | 2005-11-21 | 2007-05-24 | L'oréal | Topical compositions for promoting homeostasis of the skin |
CN101516327A (zh) * | 2006-09-25 | 2009-08-26 | 纳幕尔杜邦公司 | 化妆品组合物 |
US10933010B2 (en) | 2015-05-11 | 2021-03-02 | Hayashibara Co., Ltd. | External dermal agent |
Also Published As
Publication number | Publication date |
---|---|
EP1704849A1 (en) | 2006-09-27 |
HK1098688A1 (en) | 2007-07-27 |
TW200526262A (en) | 2005-08-16 |
US20070148120A1 (en) | 2007-06-28 |
KR20060115358A (ko) | 2006-11-08 |
EP1704849A4 (en) | 2012-01-18 |
TWI337873B (ja) | 2011-03-01 |
US20100119470A1 (en) | 2010-05-13 |
KR101101363B1 (ko) | 2012-01-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005067884A1 (ja) | しわ改善用皮膚外用剤 | |
KR101830943B1 (ko) | 수분―방출 화장 조성물 | |
JP3419734B2 (ja) | 気泡組成物、その製造方法、および化粧用組成物としてのその使用 | |
JP4825849B2 (ja) | ゲル状組成物 | |
KR101500594B1 (ko) | 수중 유형 유화 조성물 | |
US9078820B2 (en) | Oil-in-water emulsion containing an amphiphilic polymer and a silicone elastomer | |
JP2006526019A (ja) | ゲルネットワーク内に活性剤を含むパーソナルケア製品 | |
WO2008004502A1 (fr) | Préparation cosmétique pour les cheveux | |
EP2609139B1 (en) | Saccharide siloxane copolymers and methods for their preparation and use | |
JP2008163023A (ja) | シリコーン化合物および両親媒性ポリマーを含有する化粧用製品 | |
JP4590186B2 (ja) | しわ改善用皮膚外用剤 | |
JP2001288365A (ja) | 油中水エマルション形態の組成物及びその化粧品のための使用 | |
EP2609141A1 (en) | Emulsions containing saccharide siloxane copolymer emulsifiers and methods for their preparation and use | |
US20130149261A1 (en) | Emulsions containing saccharide siloxane copolymer emulsifiers and methods for their preparation and use | |
WO1997002090A1 (en) | Emulsion composition | |
JP2006062995A (ja) | しわ改善用皮膚外用剤 | |
JP3834572B2 (ja) | 水中油型エマルジョンの形態の組成物およびその使用、特に美容のための使用 | |
JP4136963B2 (ja) | 毛髪化粧料 | |
JP2009191017A (ja) | 乳化型毛髪化粧料 | |
JP2002145733A (ja) | 固形状油中水型乳化化粧料 | |
WO2007061045A1 (ja) | 粉末状乳化増粘剤を含有する毛髪処理剤 | |
JP2003012476A (ja) | 半固形状毛髪化粧料 | |
JP5300282B2 (ja) | 毛髪化粧料 | |
WO2016124441A1 (en) | Composition comprising a modified starch and magnesium silicate | |
JP4498838B2 (ja) | ポリマー組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1020067006970 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007148120 Country of ref document: US Ref document number: 10584171 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005703571 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200580002236.8 Country of ref document: CN |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
WWP | Wipo information: published in national office |
Ref document number: 2005703571 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1020067006970 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 10584171 Country of ref document: US |